Xiaojuan He
Associate Professor
Department of Translational Medicine in Bone & Joint Disease
Institute of Integrated Bioinformedicine and Translational Science
Hong Kong
Biography
Name: He Xiaojuan Academic qualifications: 1995-2000 B. Med. Nanhua University, Hengyang, China 2000-2003 M. Med. XiangYa School of Medicine, Central South University, Changsha, China 2005-2008 M.D. Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, China Present academic position: 2012- Associate Professor (By courtesy) Institute for Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University
Research Interest
Immunotherapy of tumor and rheumatoid arthritis; Immunopharmacological study on herbal medicines
Publications
-
Shaikh AB, Li F, Li M, He B, He X, Chen G, Guo B, Li D, Jiang F, Dang L, Zheng S. Present advances and future perspectives of molecular targeted therapy for osteosarcoma. International journal of molecular sciences. 2016 Apr 6;17(4):506.
-
Li D, Liu J, Guo B, Liang C, Dang L, Lu C, He X, Cheung HY, Xu L, Lu C, He B. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nature communications. 2016 Mar 7;7.
-
Liang C, Guo B, Wu H, Shao N, Li D, Liu J, Dang L, Wang C, Li H, Li S, Lau WK. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nature medicine. 2015 Mar 1;21(3):288-94.
